Orphan Drug Conference USA 2017
May 22, 2017
Orphan Drugs Conquering Rare Diseases One-by-One.
The Orphan Drug Conference USA 2017 welcomed thousands of attendees as science, industry, big pharma, and patient advocacy groups met in Washington, D.C. Their objective? To develop therapies, raise research money and bring the challenge of defeating rare diseases to the forefront. Sponsored by global events company Terrapinn, the event is in its seventh year.
Don’t move! The Balancing Act is back with a new Behind the Mystery segment and an inside look at a Broadway sensation.
We're discussing Alport syndrome, a rare, genetic, and chronic kidney condition characterized by declining kidney function which can lead to end-stage kidney disease.
When it comes to facial and body rejuvenation, discover a patient-first, non-surgical approach at Jupiter Plastic Surgery Center.